Skip to content

Incannex Healthcare Inc.

IXHL· NasdaqCore metricsCIK 1873875

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · +3.05%
Market cap
$25.47M
12.55M shares
Filings
267
$0.00
Q1 2027−100.0% FY26 yoy
-$1.94M
Q1 2027N/M FY26 yoy
-$3.44M
Q1 2027N/M FY26 yoy
$521.00K
Q1 2027derivedN/M FY26 yoy
-$0.15
Q1 2027N/M FY26 yoy
$68.27M
Q1 2027+350.2% FY26 yoy
$25.47M
—
—
0.4×
-50.56%
—

FY2026 figures · derived

Price

$2.0381.39%$8.88past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2026
$1.90M0FY 2020FY 2021FY 2024FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$0reported
FY 20252025-06-30$86,000reported
FY 20242024-06-30$12,000reported
FY 20212021-06-30$1,897,596reported
FY 20202020-06-30$604,884reported

Capital returns

Dividends and buybacks · FY2025 to FY2026
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2026—$9.40M$9.40M—12.54M sh−96.4%—
FY2025—$0.00$0.00—347.71M sh+1,870.8%—

Segments

Segments
Revenue by Segments, FY2021 to FY2021FY2021Cannabinoid Products · FY2021 · $1.90MConsolidated · FY2021 · $1.90M
LineFY2021ShareChange
Cannabinoid Products$1.90M100%—
Consolidated$1.90M100%—
Total$1.90M

From the 20-F filed Oct 31, 2023IXHL

Pharmaceutical preparations

Incannex Healthcare Inc. is the 370th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Incannex Healthcare Inc. · CIK 1873875 · Engraved from SEC EDGAR